A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors

Eric Angevin, Josep Tabernero, Elena Elez, Steven J Cohen, Rastilav Bahleda, Jean-Luc van Laethem, Christian Ottensmeier, Jose A Lopez-Martin, Sally Clive, Florence Joly, Isabelle Ray-Coquard, Luc Dirix, Jean-Pascal Machiels, Neil Steven, Manjula Reddy, Brett Hall, Thomas A Puchalski, Rajesh Bandekar, Helgi van de Velde, Brenda TrompJessica Vermeulen, Razelle Kurzrock

Research output: Contribution to journal › Article › peer-review

93 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences